日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Results of a randomized phase I gene therapy clinical trial of nononcolytic fowlpox viruses encoding T cell costimulatory molecules

一项针对编码T细胞共刺激分子的非溶瘤性禽痘病毒的随机I期基因治疗临床试验结果

Kaufman, Howard L; Kim, Dae Won; Kim-Schulze, Seunghee; DeRaffele, Gail; Jagoda, Michael C; Broucek, Joseph R; Zloza, Andrew

Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy

血清血管内皮生长因子和纤连蛋白可预测高剂量白细胞介素-2治疗的临床反应

Sabatino, Marianna; Kim-Schulze, Seunghee; Panelli, Monica C; Stroncek, David; Wang, Ena; Taback, Bret; Kim, Dae Won; Deraffele, Gail; Pos, Zoltan; Marincola, Francesco M; Kaufman, Howard L

Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma

改良型痘苗病毒安卡拉株(MVA)表达5T4和高剂量白细胞介素-2(IL-2)治疗转移性肾细胞癌患者的II期临床试验

Kaufman, Howard L; Taback, Bret; Sherman, William; Kim, Dae Won; Shingler, William H; Moroziewicz, Dorota; DeRaffele, Gail; Mitcham, Josephine; Carroll, Miles W; Harrop, Richard; Naylor, Stuart; Kim-Schulze, Seunghee

Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer

用于治疗晚期胰腺癌的痘病毒疫苗疗法

Kaufman, Howard L; Kim-Schulze, Seunghee; Manson, Kelledy; DeRaffele, Gail; Mitcham, Josephine; Seo, Kang Seok; Kim, Dae Won; Marshall, John